NCT00496236View on ClinicalTrials.gov

Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Head and Neck CancerHead and Neck Neoplasms

Interventions

DRUG

TNFerade biologic

Trial Locations (1)

60637

University of Chicago, Chicago

Sponsors

Lead Sponsor

All Listed Sponsors

lead

GenVec

INDUSTRY

NCT00496236 - Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer | Biotech Hunter | Biotech Hunter